Literature DB >> 2413806

Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies.

D T Pang, B R Sharma, J A Shafer.   

Abstract

The catalytically active, tyrosyl-phosphorylated form of insulin receptor kinase was isolated from human placenta by a procedure which exploits the propensity for the intact alpha 2 beta 2 form of insulin receptor to undergo insulin-promoted autophosphorylation at tyrosyl residues and concomitant activation as a tyrosyl kinase. Purification of tyrosyl-phosphorylated insulin receptor was effected by adsorption on and elution (with a hapten) from a column of O-phosphotyrosyl-binding antibody immobilized on protein A-Sepharose (Ab-protein A). The starting material for the purification process was protein which had been solubilized from placental membranes and purified by chromatography on immobilized wheat germ agglutinin. After chromatography on Ab-protein A to remove preexisting O-phosphotyrosyl-containing proteins, the fraction which did not adsorb to the Ab-protein A column was incubated with insulin and briefly treated with ATP so as to maximize selective autophosphorylation of insulin receptor. This material was then subjected to chromatography on Ab-protein A. Although the amount of the intact alpha 2 beta 2 form of insulin receptor present in the starting material was only a small fraction of the protein (approximately 0.2%) and only approximately 20% of the insulin-binding forms of the receptor present, it was eluted (with 10 mM p-nitrophenyl phosphate) from the column in greater than or equal to 80% purity. Chromatography on Ab-protein A appears to have an advantage over the alternative affinity chromatographic procedures which utilize immobilized insulin or antiinsulin receptor antibody to adsorb insulin receptor, since these procedures do not resolve the intact alpha 2 beta 2 form of insulin receptor from the nicked insulin-binding forms of the receptor which do not undergo insulin promoted autophosphorylation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413806     DOI: 10.1016/0003-9861(85)90491-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  28 in total

1.  Tyrosine phosphorylation of two cytosolic proteins of 50 kDa and 35 kDa in rat liver by insulin-receptor kinase in vitro.

Authors:  Y C Kwok; C C Yip
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  An Mr 180,000 protein is an endogenous substrate for the insulin-receptor-associated tyrosine kinase in human placenta.

Authors:  F Machicao; H Häring; M F White; J M Carrascosa; B Obermaier; O H Wieland
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

3.  The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency.

Authors:  F Fazioli; U H Kim; S G Rhee; C J Molloy; O Segatto; P P Di Fiore
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  A glycoprotein in the plasma membrane matrix as a major potential substrate of p60v-src.

Authors:  M Hamaguchi; M Matsuda; H Hanafusa
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

5.  Activation of liver and muscle insulin receptor tyrosine kinase activity during in vivo insulin administration in rats.

Authors:  Y T Kruszynska; P A Halban; C R Kahn; M F White
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

Review 6.  Phosphotyrosyl protein phosphatases.

Authors:  K H Lau; J R Farley; D J Baylink
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

7.  Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells: analysis by use of anti-phosphotyrosine antibodies.

Authors:  M Hamaguchi; C Grandori; H Hanafusa
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.

Authors:  M J Saad; E Araki; M Miralpeix; P L Rothenberg; M F White; C R Kahn
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

9.  Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.

Authors:  F Folli; M J Saad; J M Backer; C R Kahn
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.

Authors:  M J Saad; F Folli; J A Kahn; C R Kahn
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.